US5042723A
(en)
*
|
1986-09-01 |
1991-08-27 |
Imperial Chemical Industries Plc |
Electrostatic spraying apparatus
|
GB8621095D0
(en)
*
|
1986-09-01 |
1986-10-08 |
Ici Plc |
Electrostatic spraying apparatus
|
ATE72775T1
(de)
*
|
1987-09-22 |
1992-03-15 |
Ici Plc |
Elektrostatische spruehvorrichtung.
|
JP2587298B2
(ja)
*
|
1989-10-30 |
1997-03-05 |
オーベクス 株式会社 |
液体揮散装置
|
US5178330A
(en)
*
|
1991-05-17 |
1993-01-12 |
Ransburg Corporation |
Electrostatic high voltage, low pressure paint spray gun
|
US5605605A
(en)
*
|
1992-03-02 |
1997-02-25 |
Imperial Chemical Industries Plc |
Process for treating and sizing paper substrates
|
US5326598A
(en)
*
|
1992-10-02 |
1994-07-05 |
Minnesota Mining And Manufacturing Company |
Electrospray coating apparatus and process utilizing precise control of filament and mist generation
|
US5402945A
(en)
*
|
1993-01-22 |
1995-04-04 |
Gervan Company International |
Method for spraying plants and apparatus for its practice
|
US6703050B1
(en)
*
|
1998-09-04 |
2004-03-09 |
The Regents Of The University Of Michigan |
Methods and compositions for the prevention or treatment of cancer
|
US6397838B1
(en)
*
|
1998-12-23 |
2002-06-04 |
Battelle Pulmonary Therapeutics, Inc. |
Pulmonary aerosol delivery device and method
|
US6368562B1
(en)
|
1999-04-16 |
2002-04-09 |
Orchid Biosciences, Inc. |
Liquid transportation system for microfluidic device
|
BR0009992A
(pt)
|
1999-04-23 |
2002-01-08 |
Battelle Memorial Institute |
Pulverizador de aerossol eletro-hidrodinâmico, aparelho e processo para administrar um aerossol e processo para produzir e administrar um aerossol
|
US6485690B1
(en)
|
1999-05-27 |
2002-11-26 |
Orchid Biosciences, Inc. |
Multiple fluid sample processor and system
|
US6339107B1
(en)
|
2000-08-02 |
2002-01-15 |
Syntex (U.S.A.) Llc |
Methods for treatment of Emphysema using 13-cis retinoic acid
|
EP1935869A1
(en)
|
2000-10-02 |
2008-06-25 |
F. Hoffmann-La Roche Ag |
Retinoids for the treatment of emphysema
|
US20030181416A1
(en)
*
|
2002-01-10 |
2003-09-25 |
Comper Wayne D. |
Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
|
US20040009953A1
(en)
*
|
2002-01-10 |
2004-01-15 |
Comper Wayne D. |
Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
|
JP2005538093A
(ja)
|
2002-07-23 |
2005-12-15 |
ザ リージェンツ オブ ザ ユニバーシティー オブ ミシガン |
抗血管形成療法のための、テトラポリアンモニウムテトラチオモリブデートおよび関連化合物
|
US7189865B2
(en)
*
|
2002-07-23 |
2007-03-13 |
Attenuon, Llc |
Thiomolybdate analogues and uses thereof
|
US20060100167A1
(en)
*
|
2002-09-27 |
2006-05-11 |
Wood Christopher B |
Methods and compositions for the treatment of autoimmune disorders using clofarabine
|
US20060135463A1
(en)
*
|
2002-09-27 |
2006-06-22 |
Wood Christopher B |
Methods and compositions for the treatment of lupus using clofarabine
|
EP1556056A4
(en)
*
|
2002-10-07 |
2008-08-06 |
Radiorx Inc |
X-Nitro Compounds, Pharmaceutical Compositions And Their Uses
|
EA200500871A1
(ru)
*
|
2002-11-25 |
2006-04-28 |
Атеньюон, Ллк |
Пептиды, ингибирующие ангиогенез, миграцию клеток, инвазию клеток и пролиферацию клеток, композиции и их применение
|
ZA200504940B
(en)
*
|
2003-01-28 |
2006-09-27 |
Xenoport Inc |
Amino acid derived prodrugs of propofol, compositions and uses thereof
|
KR20050111759A
(ko)
|
2003-03-12 |
2005-11-28 |
셀진 코포레이션 |
7-아미노-이소인돌릴 화합물 및 그의 제약학적 용도
|
UA84420C2
(ru)
|
2003-04-11 |
2008-10-27 |
ПиТиСи ТЕРАПЬЮТИКС, ИНК. |
СОЕДИНЕНИЯ 1,2,4-ОКСАДИАЗОЛБЕНЗОЙНОЙ КИСЛОТЫ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ (ВАРИАНТЫ) И ПРИМЕНЕНИЕ СОЕДИНЕНИЙ ДЛЯ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ, СВЯЗАННОГО С ПРЕЖДЕВРЕМЕННОЙ ТЕРМИНАЦИЕЙ ТРАНСЛЯЦИИ ИЛИ НОНСЕНС-ОБУСЛОВЛЕННЫМ УМЕНЬШЕНИЕМ мРНК
|
AU2004247059A1
(en)
*
|
2003-05-27 |
2004-12-23 |
Attenuon L.L.C. |
Thiotungstate analogues and uses thereof
|
US20050009782A1
(en)
*
|
2003-07-09 |
2005-01-13 |
Comper Wayne D. |
Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
|
US7230003B2
(en)
*
|
2003-09-09 |
2007-06-12 |
Xenoport, Inc. |
Aromatic prodrugs of propofol, compositions and uses thereof
|
EP2065383A1
(en)
|
2003-11-19 |
2009-06-03 |
Signal Pharmaceuticals, Inc. |
Indazole compounds and methods of use thereof as protein kinase inhibitors
|
EP1729784A1
(en)
*
|
2004-02-23 |
2006-12-13 |
Attenuon, LLC |
Formulations of thiomolybdate or thiotungstate compounds and uses thereof
|
CA2571407A1
(en)
*
|
2004-07-12 |
2006-02-16 |
Xenoport, Inc. |
Amino acid derived prodrugs of propofol, compositions and uses thereof
|
WO2006017351A1
(en)
*
|
2004-07-12 |
2006-02-16 |
Xenoport, Inc. |
Prodrugs of propofol, compositions and uses thereof
|
US20060128676A1
(en)
*
|
2004-07-13 |
2006-06-15 |
Pharmacofore, Inc. |
Compositions of nicotinic agonists and therapeutic agents and methods for treating or preventing diseases or pain
|
PT1824482E
(pt)
|
2004-12-17 |
2014-05-13 |
Anadys Pharmaceuticals Inc |
Compostos 3h-oxazolo e 3h-tiazolo[4,5-d]pirimidin-2-ona 3,5- -di-substituídos e 3,5,7-tri-substituídos e seus pró- -fármacos
|
JP2008525501A
(ja)
*
|
2004-12-23 |
2008-07-17 |
ゼノポート,インコーポレイティド |
セリンアミノ酸誘導のプロポフォールのプロドラッグ、その使用及び結晶体
|
CA2596357A1
(en)
|
2005-02-01 |
2006-08-10 |
Attenuon, Llc |
Acid addition salts of ac-phscn-nh2
|
US20070135380A1
(en)
|
2005-08-12 |
2007-06-14 |
Radiorx, Inc. |
O-nitro compounds, pharmaceutical compositions thereof and uses thereof
|
US7507842B2
(en)
*
|
2005-08-12 |
2009-03-24 |
Radiorx, Inc. |
Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
|
WO2007022535A2
(en)
|
2005-08-19 |
2007-02-22 |
Pharmacofore, Inc. |
Prodrugs of active agents
|
MX2008012064A
(es)
*
|
2006-03-23 |
2008-12-17 |
Amgen Inc |
Compuestos de amida 1-fenilsulfonil-diaza-heterociclica y sus usos como moduladores de hidroxiesteroide deshidrogenadas.
|
ES2456674T3
(es)
|
2006-05-26 |
2014-04-23 |
Signature Therapeutics, Inc. |
Liberación controlada de opioides fenólicos
|
TW200808695A
(en)
|
2006-06-08 |
2008-02-16 |
Amgen Inc |
Benzamide derivatives and uses related thereto
|
ATE476418T1
(de)
*
|
2006-06-08 |
2010-08-15 |
Amgen Inc |
Benzamidderivate und assoziierte verwendungen
|
US7462611B2
(en)
|
2006-06-22 |
2008-12-09 |
Anadys Pharmaceuticals, Inc. |
Pyrro[1,2-b]pyridazinone compounds
|
JP5345527B2
(ja)
|
2006-06-22 |
2013-11-20 |
アナディス ファーマシューティカルズ インク |
プロドラッグである5−アミノ−3−(3’−デオキシ−β−D−リボフラノシル)−チアゾロ[4,5−d]ピリミジン−2,7−ジオン
|
DE602007012881D1
(en)
|
2006-07-18 |
2011-04-14 |
Anadys Pharmaceuticals Inc |
Carbonat- und carbamat-prodrugs von thiazolo ä4,5-dü-pyrimidinen
|
CA2659155A1
(en)
*
|
2006-07-20 |
2008-01-24 |
Amgen Inc. |
Substituted azole aromatic heterocycles as inhibitors of 11.beta.-hsd-1
|
US7673820B2
(en)
*
|
2006-12-18 |
2010-03-09 |
Yehuda Ivri |
Subminiature thermoelectric fragrance dispenser
|
EP2121580A2
(en)
*
|
2006-12-26 |
2009-11-25 |
Amgen Inc. |
N-cyclohexyl benzamides and benzeneacetamides as inhibitors of 11-beta-hydroxysteroid dehydrogenases
|
US8633186B2
(en)
|
2007-06-08 |
2014-01-21 |
Senomyx Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
US7928111B2
(en)
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
US9603848B2
(en)
*
|
2007-06-08 |
2017-03-28 |
Senomyx, Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
US20080306076A1
(en)
*
|
2007-06-08 |
2008-12-11 |
Senomyx, Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
WO2009003061A1
(en)
|
2007-06-25 |
2008-12-31 |
Fred Hutchinson Cancer Research Center |
Methods and compositions regarding polychalcogenide compositions
|
SI2194783T1
(sl)
|
2007-08-10 |
2017-12-29 |
Vm Discovery, Inc. |
Sestavki in metode za modulatorje apoptose
|
MX2011001155A
(es)
|
2008-07-31 |
2011-07-29 |
Senomyx Inc |
Composiciones que comprenden mejoradores del dulzor, y métodos para prepararlas.
|
WO2010014666A2
(en)
|
2008-07-31 |
2010-02-04 |
Senomyx, Inc. |
Processes and intermediates for making sweet taste enhancers
|
TWI480272B
(zh)
|
2008-10-09 |
2015-04-11 |
Anadys Pharmaceuticals Inc |
藉由5,6-二氫-1h-吡啶-2-酮與一或多種其他抗病毒化合物的組合物抑制c型肝炎病毒的方法
|
EP2356109B1
(en)
|
2008-10-10 |
2016-12-07 |
VM Discovery, Inc. |
Compositions and methods for treating alcohol use disorders, pain and other diseases
|
WO2010077680A2
(en)
|
2008-12-08 |
2010-07-08 |
Vm Discovery Inc. |
Compositions of protein receptor tyrosine kinase inhibitors
|
FR2950545B1
(fr)
*
|
2009-09-29 |
2012-11-30 |
Centre Nat Rech Scient |
Dispositif et procede de projection electrostatique d'un liquide, injecteur de carburant incorporant ce dispositif et utilisations de ce dernier
|
US8471041B2
(en)
*
|
2010-02-09 |
2013-06-25 |
Alliant Techsystems Inc. |
Methods of synthesizing and isolating N-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same
|
EP2603098A4
(en)
|
2010-08-12 |
2018-01-17 |
Senomyx, Inc. |
Method of improving stability of sweet enhancer and composition containing stabilized sweet enhancer
|
US9327037B2
(en)
|
2011-02-08 |
2016-05-03 |
The Johns Hopkins University |
Mucus penetrating gene carriers
|
WO2012158271A1
(en)
|
2011-04-06 |
2012-11-22 |
Anadys Pharmaceuticals, Inc. |
Bridged polycyclic compounds as antiviral agents
|
US8664247B2
(en)
|
2011-08-26 |
2014-03-04 |
Radiorx, Inc. |
Acyclic organonitro compounds for use in treating cancer
|
US9139519B2
(en)
|
2011-10-07 |
2015-09-22 |
Epicentrx, Inc. |
Organonitro thioether compounds and medical uses thereof
|
WO2013052803A2
(en)
|
2011-10-07 |
2013-04-11 |
Radiorx, Inc. |
Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products
|
US8586527B2
(en)
|
2011-10-20 |
2013-11-19 |
Jaipal Singh |
Cerivastatin to treat pulmonary disorders
|
JP6308679B2
(ja)
|
2011-12-14 |
2018-04-11 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
粘膜浸透が増強されたかまたは炎症が低減されたナノ粒子
|
US9957247B2
(en)
|
2012-06-07 |
2018-05-01 |
Georgia State University Research Foundation, Inc. |
SecA inhibitors and methods of making and using thereof
|
BR112015002380B1
(pt)
|
2012-08-06 |
2021-09-28 |
Firmenich Incorporated |
Composto, composições ingeríveis, processos para aumentar o sabor doce de composição e formulação flavorizante concentrada
|
DK2900230T3
(da)
|
2012-09-27 |
2018-11-12 |
Childrens Medical Ct Corp |
Forbindelser til behandling af adipositas og fremgangsmåder til anvendelse deraf
|
JO3155B1
(ar)
|
2013-02-19 |
2017-09-20 |
Senomyx Inc |
معدِّل نكهة حلوة
|
SI3074033T1
(sl)
|
2013-11-26 |
2019-03-29 |
The Children's Medical Center Corporation |
Spojine za zdravljenje debelosti in postopki njihove uporabe
|
KR101723997B1
(ko)
|
2014-02-05 |
2017-04-06 |
브이엠 온콜로지 엘엘씨 |
화합물의 조성물 및 이의 용도
|
WO2015153933A1
(en)
|
2014-04-03 |
2015-10-08 |
The Children's Medical Center Corporation |
Hsp90 inhibitors for the treatment of obesity and methods of use thereof
|
US10335406B2
(en)
|
2015-10-01 |
2019-07-02 |
Elysium Therapeutics, Inc. |
Opioid compositions resistant to overdose and abuse
|
US9808452B2
(en)
|
2015-10-01 |
2017-11-07 |
Elysium Therapeutics, Inc. |
Polysubunit opioid prodrugs resistant to overdose and abuse
|
US10342778B1
(en)
|
2015-10-20 |
2019-07-09 |
Epicentrx, Inc. |
Treatment of brain metastases using organonitro compound combination therapy
|
US9987270B1
(en)
|
2015-10-29 |
2018-06-05 |
Epicentrix, Inc. |
Treatment of gliomas using organonitro compound combination therapy
|
SG11201805942UA
(en)
|
2016-01-11 |
2018-08-30 |
Epicentrx Inc |
Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone
|
BR112019007453A2
(pt)
|
2016-10-14 |
2019-07-16 |
Epicentrx Inc |
organonitro de sulfoxialquila e compostos relacionados e composições farmacêuticas para uso em medicina
|
AU2018234911B2
(en)
|
2017-03-17 |
2024-04-18 |
Elysium Therapeutics, Inc. |
Polysubunit opioid prodrugs resistant to overdose and abuse
|
MX2020000265A
(es)
|
2017-07-07 |
2020-07-22 |
Epicentrx Inc |
Composiciones para la administración parenteral de agentes terapéuticos.
|
US11510901B2
(en)
|
2018-01-08 |
2022-11-29 |
Epicentrx, Inc. |
Methods and compositions utilizing RRx-001 combination therapy for radioprotection
|
EP3773614A1
(en)
|
2018-04-12 |
2021-02-17 |
Matrx Therapeutics Corporation |
Compositions and methods for treating elastic fiber breakdown
|
MX2021001193A
(es)
|
2018-08-07 |
2021-04-28 |
Firmenich Incorporated |
2,2-dioxidos de 4-amino-1h-benzo[c][1,2,6]tiadiazina 5-sustituidos y formulaciones y usos de los mismos.
|
CN114144261B
(zh)
*
|
2019-05-17 |
2024-05-28 |
怡色公司 |
用于管理细颗粒浓度的设备和方法
|
WO2022246106A1
(en)
|
2021-05-20 |
2022-11-24 |
Climb Works LLC |
Electrostatic sprayer
|
CN114308433B
(zh)
*
|
2021-12-20 |
2024-01-05 |
江苏大学 |
一种气力辅助静电喷头
|
WO2023178283A1
(en)
|
2022-03-18 |
2023-09-21 |
Epicentrx, Inc. |
Co-crystals of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone and methods
|
WO2023215227A1
(en)
|
2022-05-02 |
2023-11-09 |
Epicentrx, Inc. |
Systems and methods to improve exercise tolerance
|
WO2023215229A1
(en)
|
2022-05-02 |
2023-11-09 |
Epicentrx, Inc. |
Compositions and methods for treatment of pulmonary hypertension
|
TW202408485A
(zh)
|
2022-06-13 |
2024-03-01 |
美商埃皮辛特瑞科斯公司 |
用於減少癌症治療中不良副作用之組合物及方法
|
WO2024098009A1
(en)
|
2022-11-04 |
2024-05-10 |
Epicentrx, Inc. |
Rrx-001 for minimizing post-infarct adverse ventricular remodeling and complications
|
WO2024124152A1
(en)
|
2022-12-08 |
2024-06-13 |
Epicentrx, Inc. |
Rrx-001 for the treatment of a hemoglobinopathy
|